Skopos Labs, Inc. I Teos Therapeutics, Inc. Transaction History
Skopos Labs, Inc.
- $813 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding ITOS
# of Institutions
13Shares Held
4.22MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.73MShares$37.9 Million0.0% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL152KShares$1.54 Million0.01% of portfolio
-
Ea Series Trust Havertown, PA101KShares$1.03 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL60.4KShares$613,0700.0% of portfolio
-
Tekla Capital Management LLC45.7KShares$464,2100.02% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $361M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...